论文部分内容阅读
自1993年开始利用血液净化技术治疗30例高胆红素血症的肝病病人，经过1－9次（平均4．76次）的治疗，其总胆红素平均降至85μmol／L以下的天数为18．1，生存率为53．3％（16/30）；而对照组分别为44天，生存率23．3％（7/30），（P＜0．05）。结论：利用血液净化技术治疗高胆红素血症较之单纯内科常规治疗可显著缩短治疗时间，提高病人生存率。
Thirty patients with hyperbilirubinemia who have been treated with blood purification since 1993 have a mean total bilirubin reduction of less than 85 μmol / L after 1-9 sessions (mean 4.76 sessions) of treatment For 18.1, the survival rate was 53.3% (16/30); while the control group were 44 days, the survival rate was 23.3% (7/30), (P <0.05). Conclusion: The treatment of hyperbilirubinemia with blood purification technology can significantly shorten the treatment time and improve the survival rate of patients compared with the conventional medical treatment alone.